Delivery Order SPE2DB25D3404-SPE2DB25FUMVT

Award Date 4/8/25
Potential Completion Date 4/9/25
Potential Value $4.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,843.14, is for the delivery of DEXCOM G7 SENSORS, which are medical devices used for diabetes management. The contract has a firm fixed price pricing type and an ultimate completion date of September 17, 2024. The contract is not designated with a set-aside requirement, indicating open...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,439.33 firm fixed-price contract is for the provision of DEXCOM G7 SENSORS, a medical device used for diabetes management. The contract has a period of performance through February 19, 2025 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,082.76 contract is for the delivery of DEXCOM G7 SENSORS, a type of medical device, with a completion date of April 9, 2025. The contract does not have a set-aside designation, indicating it was open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,762.24 firm-fixed-price contract is for the procurement of DEXCOM G7 SENSORS, which are medical devices used for diabetes management. The contract has an ultimate completion date of April 4, 2025 and is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,394.55, is for the delivery of DEXCOM G7 SENSORS, a medical device used for diabetes management. The contract has an ultimate completion date of May 6, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation indicated. The contract is part of...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,541.35 contract is for the provision of DEXCOM G7 SENSORS, a type of medical device, with a period of performance through March 4, 2025. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the...
This is a $1,606.85 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXCOM G7 SENSORS, medical devices used for diabetes management. The contract has an ultimate completion date of April 8, 2025 and was awarded on April 7, 2025. There is no set-aside designation for this contract. Amerisourcebergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,727.73 firm fixed-price delivery order is for DEXCOM G7 SENSORS, a medical supply item. The contract has an ultimate completion date of November 19, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,050.80 firm fixed-price delivery order is for the provision of DEXCOM G7 Sensors, with an ultimate completion date of June 10, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is a for-profit organization that has been registered in the System for Award...
This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,932.05 firm fixed price contract is for the procurement of DEXCOM G7 SENSORS, a medical device used for diabetes management. The contract has a June 24, 2024 completion date and is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB25D3404
    Indefinite Delivery Contract
  • SPE2DB25D3404-SPE2DB25FUMVT
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,711.92 firm-fixed-price contract is to provide DEXCOM G7 SENSORS, a medical device used for glucose monitoring. The contract has an ultimate completion date of April 9, 2025 and was awarded on April 8, 2025. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company maintains several Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice, valued at $999,999,999 and $750,000 respectively, which serve as primary vehicles for providing a comprehensive range of pharmaceutical products and medical supplies to support government medical programs. This specific delivery order is not designated with a set-aside requirement, indicating open competition.

Generated 7/8/25, 2:24 PM